Page 45
A n n u a l S u mm i t o n
Hepatology and Pancreatic
Diseases
November 12-13 , 2018
Par i s , France
Journal of Clinical Gastroenterology and Hepatology
ISSN: 2575-7733
Hepatology and Pancreatic Diseases 2018
A
s many as 200 million people worldwide are infected with hepatitis C virus (HCV) and more than 350,000 people die yearly
from hepatitis C-related diseases (WHO, June 2011). There is no preventive vaccine available for HCV due to its highly
mutable nature evidenced by the presence of more than 50 subtypes of HCV. In the present study, the water extract of the leaves
of the wild Egyptian artichoke (WEA) (
Cynara cardunculus
L. var. sylvestris (Lam.) Fiori) showed improvement of HCV infection
symptoms through the clinical investigation of WEA extract on some infected Egyptian patients. The results showed outstanding
activity against HCV and its complications such as ascites and jaundice by measuring the PCR, and liver functions such as ALT,
and AST
1
. The phytochemistry of the WEA extract and its subsequent evaluation of inhibition capacity
in vitro
using cell-culture
derived HCV resulted in the identification of two potent sesquiterpene lactones showing
in vitro
activity against all genotypes
2
.
Their structural elucidation was done by extensive spectroscopic tools such as NMR and HR-MS spectroscopy. The absolute
configuration was determined by TDDFT ECD calculations and comparison with the experimental CD spectra. Cynaropicrin and
grosheimol showed EC
50
at 1.03 μM, and 1.27 μM, by using a luciferase-carrying reporter virus. Time-of-addition experiments
revealed that these compounds inhibited HCV virus at a time-point during entry. Finally, the results showed that compounds
cynaropicrin and grosheimol inhibited HCV particles from genotypes 1a, 1b, 2b, 3a, 4a, 5a, 6a and 7a indicating that these
compounds inhibit HCV cell entry independently of viral genotype or subtype. Most important is that compound cynaropicrin can
inhibit HCV through many important mechanisms: cell-entry inhibitor, inhibition of cell to cell coinfection, antihyperlipedemic and
antitumor activities
3
. There is a plenty of publications confirmed that cynaropicrin is a very promising drug as antitumor agent3.
elsebai72@yahoo.comPromising Natural Compounds for Treatment of
Hepatitis C Virus and its Complications
Mahmoud F. Elsebai
Mansoura University, Egypt
J Clin Gastroenterol Hepatol 2018, Volume:2
DOI: 10.21767/2575-7733-C3-009




